Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/1106 : 26Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FWRDForward Air Corporation
2024/06/1106 : 26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OFIXOrthofix Medical Inc
2024/06/1106 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WESTWWestrock Coffee Company
2024/06/1106 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REAXReal Brokerage Inc
2024/06/1106 : 25Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:KPEAKun Peng International Ltd (QB)
2024/06/1106 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ELFe l f Beauty Inc
2024/06/1106 : 25PR Newswire (US)Consumer Network Attached Storage (NAS) Market size is set to grow by USD 36.49 billion from 2024-2028, Increasing need for video surveillance systems boost the market, Technavio
2024/06/1106 : 25PR Newswire (US)Smart Kitchen Appliance Market size is set to grow by USD 22.38 billion from 2024-2028, Growing demand for premium, innovative appliances boost the market, Technavio
2024/06/1106 : 24Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:KPEAKun Peng International Ltd (QB)
2024/06/1106 : 24Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNYSE:BHRBraemar Hotels and Resorts Inc
2024/06/1106 : 24Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
2024/06/1106 : 24PR Newswire (US)ALZHEIMER'S DRUG DISCOVERY FOUNDATION'S (ADDF) STATEMENT ON FDA ADVISORY COMMITTEE'S ENDORSEMENT OF DONANEMAB
2024/06/1106 : 23Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:DODRWDiamond Offshore Drilling Inc (PK)
2024/06/1106 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWRDForward Air Corporation
2024/06/1106 : 23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:UAMYUnited States Antimony Corp
2024/06/1106 : 23Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:OUNZVanEck Merk Gold Trust
2024/06/1106 : 22Edgar (US Regulatory)Form 8-K - Current reportAMEX:SINGSinglePoint Inc
2024/06/1106 : 22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:BPAQFBP Plc (PK)
2024/06/1106 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMDAdvanced Micro Devices Inc
2024/06/1106 : 22Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]USOTC:TSNDFTerrascend Corporation (QX)
2024/06/1106 : 22Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AMSWAAmerican Software Inc
2024/06/1106 : 22Edgar (US Regulatory)Form 8-K - Current reportNYSE:SEMRSEMrush Holdings Inc
2024/06/1106 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SMMESmartMetric Inc (PK)
2024/06/1106 : 22Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:KPEAKun Peng International Ltd (QB)
2024/06/1106 : 22Business WireZimCal Urges All Stockholders to Vote for Its Board Candidates Before the June 11th, 2024 Shareholder MeetingNASDAQ:MFINMedallion Financial Corporation
2024/06/1106 : 22GlobeNewswire Inc.GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaineEU:GNFTGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisTG:XUPGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaineTG:XUPGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisEU:GNFTGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisEU:GNFTGenfit

最近閲覧した銘柄

Delayed Upgrade Clock